Yokohama, Japan

Hiroaki Ueno

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Chemical Industries Limited. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroaki Ueno. Retrieved from https://idiyas.com/inventor/hiroaki-ueno-xdr6cns4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroaki Ueno: Innovator in Corticoid Derivatives

Introduction

Hiroaki Ueno is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of corticoid derivatives. His work focuses on creating compounds that offer therapeutic benefits with minimal side effects.

Latest Patents

Ueno holds a patent for "Corticoid derivatives and process for production thereof." This patent describes novel corticoid 17.alpha.-alkoxycarbonyl carboxylate derivatives. These derivatives exhibit strong topical anti-inflammatory activity while demonstrating extremely weak systemic adverse reactions. They are particularly useful in treating various conditions, including acute and chronic eczema, seborrheic eczema, contact dermatitis, atopic dermatitis, and asthma.

Career Highlights

Hiroaki Ueno is associated with Mitsubishi Chemical Industries Limited, where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential to improve patient outcomes through effective treatments.

Collaborations

Ueno has collaborated with notable colleagues, including Issei Nitta and Akira Maruyama. Their combined expertise has contributed to advancements in the development of corticoid derivatives.

Conclusion

Hiroaki Ueno's contributions to the field of corticoid derivatives highlight his commitment to improving therapeutic options for patients. His innovative work continues to pave the way for advancements in pharmaceutical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…